Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products... Show more
Get AI intraday alerts
A.I. Advisor
published Earnings
AZTR is expected to report earnings to rise 47.06% to -25 cents per share on November 11
Q3'26
Est.
$-0.25
Q2'26
Beat
by $0.54
Q1'26
Beat
by $0.77
Q4'25
Beat
by $1.37
Q3'25
Missed
by $0.46
The last earnings report on August 13 showed earnings per share of -17 cents, beating the estimate of -70 cents. With 35.52K shares outstanding, the current market capitalization sits at 44.39M.